21 – 30 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
- Contribution to journal › Article
-
Mark
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations
- Contribution to journal › Article
-
Mark
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins
- Contribution to journal › Article
-
Mark
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
- Contribution to journal › Scientific review
- 2014
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
- Contribution to journal › Article
-
Mark
A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations
- Contribution to journal › Article
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
- Contribution to journal › Article
-
Mark
Efficient identification of miRNAs for classification of tumor origin
- Contribution to journal › Article
-
Mark
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule
- Contribution to journal › Article
